Answers are grounded in this paper and cite their sources.
Introduction Antimicrobial resistance remains a major global public health challenge that necessitates novel drugs with a low resistance rate. Methods Herein, we evaluate TGV-49, a novel broad-spectrum antimicrobial agent, against multidrug-resistant Gram-negative bacteria, including ESKAPE pathogens ( Acinetobacter baumannii , Pseudomonas aeruginosa , and Klebsiella pneumoniae ) and pathogens from agriculture that infect humans ( Ralstonia solanacearum and Aeromonas hydrophila ). Results TGV-49 was highly effective in overcoming resistance to conventional antibiotics. The experimental evolution of A. baumannii using a morbidostat revealed minimal development of resistance. Conclusion Our findings suggest TGV-49 as a potential alternative for combating MDR infections in clinical and agricultural settings.
No takes yet. Share an insight, caveat, or question.
Tetz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: